Showing 671-680 of 9099 results for "".
Differin Goes OTC, ISDIN Comes to America, Understand AD
https://practicaldermatology.com/topics/psoriasis/dermwiretv-differin-goes-otc-isdin-comes-to-america-understand-ad/18762/Barcelona-based ISDIN is officially operating in the US. The company—which operates in Europe, Latin America, and Asia—is bringing its skincare products to the US market. Regeneron Pharmaceuticals, Sanofi Genzyme, the National Eczema Association, and the Dermatology Nurses Association launch UnderVanquish Approved for Circumferential Fat Reduction; Acquisition News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-vanquish-approved-for-circumferential-fat-reduction-acquisition-news/18884/BTL's Vanquish Cleared for Circumferential Fat Reduction of the Abdomen, Filler Injections Gain Popularity Off the Face, Protein Linked to Aggressive Melanomas, and new acquisitions at Kythera, Lumenis, XTRAC.ASDS BCC Recommendations; Bad Online Reviews for Derms
https://practicaldermatology.com/topics/practice-management/dermwiretv-asds-bcc-recommendations-bad-online-reviews-for-derms/18906/This edition of DermWireTV, from the editors of Practical Dermatology® magazine reviews the new ASDS Consensus Recommendation for the management of Basal Cell Carcinoma (BCC). An expert panel found Mohs micrographic surgery is highly cost effective. In other news, researchers find that dermatologistAsk an Expert: Sheila Fallon Friedlander, MD on the Molluscum Pipeline
https://practicaldermatology.com/topics/general-topics/ask-an-expert-sheila-fallon-friedlander-md-on-the-molluscum-pipeline/19006/Sheila Fallon Friedlander, MD talks to host Adam Friedman, MD about the pipeline of treatments for molluscum in pediatric patients. From NewDermMD.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.Acquiring An Education In Cosmetic Dermatology
https://practicaldermatology.com/topics/practice-management/acquiring-an-education-in-cosmetic-dermatology/19024/With many residency programs not emphasizing cosmetic dermatology, Kristina Goldenberg, MD gives advice on how to be proactive in achieving an education in aesthetics.Allergan Commemorates 25th Anniversary of the First Two Approved Uses of BOTOX® (onabotulinumtoxinA)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/allergan-commemorates-25th-anniversary-of-the-first-two-approved-uses-of-botox-onabotulinumtoxina-/19136/Allergan, Inc. (NYSE: AGN) today announced the launch of a video recognizing the physician pioneers and patient communities who contributed to the development of BOTOX® (onabotulinumtoxinA), one of the most recognized pharmaceutical brands in the United States. The video kicks off a year-long campaiDermwireTV — Sun Rises, ICD-10 is Delayed…Again
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-sun-rises-icd-10-is-delayed-again/19139/In this week's DermwireTV, Sun acquires Ranbaxy, ICD-10 gets unexpectedly delayed, and Murad Alam recaps the ASLMS conference.ARTAS in Practice
https://practicaldermatology.com/topics/practice-management/artas-feinberg/19191/Dr. Feinberg describes how he incorporated the ARTAS Robotic Procedure into his practice.ARION, Alexandrite Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/arion-alexandrite-laser-system-by-quantel-derma/19377/ARION by Quantel Derma - High-end Solution for Hair Removal. ARION is the alexandrite laser system for effective hair removal with 755 nm wavelength. The versatile system is also suitable for treatment of vascular lesions and benign pigmented skin changes. The special Burst Mode with short sub-pulse